F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding F-star Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 40 | 53 | +13 |
| Shares | 8.18M | 7.19M | −986.8K (−12.1%) |
| Value | $29.0M | $45.1M | +$16.0M (+55.2%) |
New holders (21)
Institutions that held F-star Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gabelli Funds LLC | 168,828 | $1.06M | 0.01% |
| Susquehanna International Group, LLP | 147,934 | $926.0K | 0.00% |
| Gabelli & Co Investment Advisers, Inc. | 115,650 | $724.0K | 0.09% |
| Maven Securities LTD | 113,859 | $713.0K | 0.13% |
| Ergoteles LLC | 107,420 | $672.0K | 0.02% |
| Citigroup Inc | 78,000 | $488.0K | 0.00% |
| Knott David M Jr | 75,454 | $472.0K | 0.22% |
| Formidable Asset Management, LLC | 61,090 | $382.0K | 0.09% |
| Toroso Investments, LLC | 61,090 | $382.0K | 0.01% |
| BCK Capital Management LP | 52,000 | $326.0K | 0.25% |
| Prelude Capital Management, LLC | 36,278 | $227.0K | 0.01% |
| PenderFund Capital Management Ltd. | 22,950 | $185.0K | 0.05% |
| Diametric Capital, LP | 17,500 | $110.0K | 0.08% |
| Wolverine Trading, LLC | 16,351 | $104.0K | 0.00% |
| Charles Schwab Investment Management Inc | 12,327 | $78.0K | 0.00% |
| Simplex Trading, LLC | 8,717 | $54.0K | 0.00% |
| Urban Wealth Management, LLC | 4,691 | $29.0K | 0.10% |
| Wolverine Asset Management LLC | 2,200 | $13.0K | 0.00% |
| Total Clarity Wealth Management, Inc. | 2,000 | $13.0K | 0.01% |
| FNY Investment Advisers, LLC | 2,000 | $12.0K | 0.01% |
| Cannell Capital LLC | 1,804 | $11.0K | 0.00% |
Sold out (8)
Institutions that held F-star Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 900,000 | $3.19M |
| Anson Funds Management LP | 185,261 | $658.0K |
| Millennium Management LLC | 85,834 | $305.0K |
| D. E. Shaw & Co., Inc. | 15,865 | $56.0K |
| Marshall Wace, LLP | 10,456 | $37.0K |
| Tower Research Capital LLC (TRC) | 3,065 | $11.0K |
| Bank of America Corp | 162 | $1.00K |
| Cubist Systematic Strategies, LLC | 66 | $0 |